Youngki Cho1,2, Junghwa Do1, Sunyoung Jung3, Ohyun Kwon4,5, Jae Yong Jeon6. 1. Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-gu, 05505, Seoul, South Korea. 2. Department of Physical Therapy, Graduate School, Yonsei University, Wonju, South Korea. 3. Department of Physical Therapy, Graduate School, Hosan University, Gyeongsan, South Korea. 4. Department of Physical Therapy, Graduate School, Yonsei University, Wonju, South Korea. kwonoy@yonsei.ac.kr. 5. Laboratory of Kinetic Ergocise Based on Movement Analysis, Department of Physical Therapy, Graduate School, Yonsei University, 234 Maeji-ri, Heungeop-Myeon, Wonju, Kangwon-Do, 220-710, South Korea. kwonoy@yonsei.ac.kr. 6. Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-gu, 05505, Seoul, South Korea. jyjeon71@gmail.com.
Abstract
PURPOSE: The aim of this study was to evaluate the effects of physical therapy (PT) combined with manual lymphatic drainage (MLD) on shoulder function, pain, lymphedema, visible cords, and quality of life (QOL) in breast cancer patients with axillary web syndrome (AWS). METHODS: In this prospective, randomized trial, 41 breast cancer patients with visible and palpable cords on the arm and axilla and a numeric rating scale (NRS) pain score of >3 were randomly assigned to PT (3 times/week for 4 weeks; n = 20) and PT combined with MLD (5 times/week for 4 weeks; PTMLD; n = 21) groups. MLD was performed by a physical therapist and the patients themselves during week 1 and weeks 2-4, respectively. Arm volume, shoulder function (muscular strength; active range of motion; and disabilities of the arm, shoulder, and hand [DASH]); QOL (European Organization for Research and Treatment of Cancer Core and Breast Cancer-Specific QOL questionnaires), and pain (NRS) were assessed at baseline and after 4 weeks of treatment. RESULTS: QOL including functional and symptom aspects, shoulder flexor strength, DASH, and NRS scores were significantly improved in both groups after the 4-week intervention (P < 0.05). NRS score and arm volume were significantly lower in the PTMLD group than in the PT group (P < 0.05). Lymphedema was observed in the PT (n = 6), but not PTMLD, group (P < 0.05). CONCLUSIONS: PT improves shoulder function, pain, and QOL in breast cancer patients with AWS and combined with MLD decreases arm lymphedema.
PURPOSE: The aim of this study was to evaluate the effects of physical therapy (PT) combined with manual lymphatic drainage (MLD) on shoulder function, pain, lymphedema, visible cords, and quality of life (QOL) in breast cancer patients with axillary web syndrome (AWS). METHODS: In this prospective, randomized trial, 41 breast cancer patients with visible and palpable cords on the arm and axilla and a numeric rating scale (NRS) pain score of >3 were randomly assigned to PT (3 times/week for 4 weeks; n = 20) and PT combined with MLD (5 times/week for 4 weeks; PTMLD; n = 21) groups. MLD was performed by a physical therapist and the patients themselves during week 1 and weeks 2-4, respectively. Arm volume, shoulder function (muscular strength; active range of motion; and disabilities of the arm, shoulder, and hand [DASH]); QOL (European Organization for Research and Treatment of Cancer Core and Breast Cancer-Specific QOL questionnaires), and pain (NRS) were assessed at baseline and after 4 weeks of treatment. RESULTS: QOL including functional and symptom aspects, shoulder flexor strength, DASH, and NRS scores were significantly improved in both groups after the 4-week intervention (P < 0.05). NRS score and arm volume were significantly lower in the PTMLD group than in the PT group (P < 0.05). Lymphedema was observed in the PT (n = 6), but not PTMLD, group (P < 0.05). CONCLUSIONS: PT improves shoulder function, pain, and QOL in breast cancer patients with AWS and combined with MLD decreases arm lymphedema.
Entities:
Keywords:
Axillary web syndrome; Breast neoplasms; Physical therapy modalities; Quality of life
Authors: Anke Bergmann; Valéria Vasconcellos Mendes; Ricardo de Almeida Dias; Blenda do Amaral E Silva; Maria Giseli da Costa Leite Ferreira; Erica Alves Nogueira Fabro Journal: Breast Cancer Res Treat Date: 2011-10-11 Impact factor: 4.872
Authors: A E Giuliano; P I Haigh; M B Brennan; N M Hansen; M C Kelley; W Ye; E C Glass; R R Turner Journal: J Clin Oncol Date: 2000-07 Impact factor: 44.544
Authors: O Leduc; E Fumière; S Banse; C Vandervorst; A Clément; T Parijs; F Wilputte; F Maquerlot; M Ezquer Echandia; A Tinlot; A Leduc Journal: Lymphology Date: 2014-12 Impact factor: 1.286
Authors: María Torres Lacomba; Orlando Mayoral Del Moral; José Luís Coperias Zazo; María José Yuste Sánchez; Jean-Claude Ferrandez; Alvaro Zapico Goñi Journal: Breast Cancer Res Treat Date: 2009-03-21 Impact factor: 4.872
Authors: Bárbara Reis Wariss; Rejane Medeiros Costa; Ana Carolina Padula Ribeiro Pereira; Rosalina Jorge Koifman; Anke Bergmann Journal: Support Care Cancer Date: 2016-10-04 Impact factor: 3.603
Authors: Paula M C Donahue; Rachelle Crescenzi; Allison O Scott; Vaughn Braxton; Aditi Desai; Seth A Smith; John Jordi; Ingrid M Meszoely; Ana M Grau; Rondi M Kauffmann; Raeshell S Sweeting; Kandace Spotanski; Sheila H Ridner; Manus J Donahue Journal: Lymphat Res Biol Date: 2017-03 Impact factor: 2.589
Authors: Paula M C Donahue; Rachelle Crescenzi; Kalen J Petersen; Maria Garza; Niral Patel; Chelsea Lee; Sheau-Chiann Chen; Manus J Donahue Journal: Lymphat Res Biol Date: 2021-11-08 Impact factor: 2.349
Authors: Almir Jose Sarri; Eduardo Tinois da Silva; Rene Aloisio da Costa Vieira; Katia Hiromoto Koga; Pedro Henrique Moriguchi Cação; Vitor Coca Sarri; Sonia Marta Moriguchi Journal: Breast Cancer (Dove Med Press) Date: 2017-04-19
Authors: Paula A Ospina; Alyssa McComb; Lesley E Pritchard-Wiart; David D Eisenstat; Margaret L McNeely Journal: Cochrane Database Syst Rev Date: 2021-08-03